Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
J Med Primatol ; 50(1): 36-45, 2021 02.
Article in English | MEDLINE | ID: mdl-33219623

ABSTRACT

BACKGROUND: Alouatta spp. are highly susceptible to yellow fever (YF) infection and develop an often fatal disease. The threat posed by an outbreak started in 2016 leads us to investigate vaccination as a potential tool in preventing YF in non-human primates (NHP). METHODS: Susceptible howler monkeys were immunized with three different concentrations of the human Brazilian commercial YF17DD vaccine. Post-vaccination viremia/RNAemia, immunogenicity, and safety were characterized. RESULTS: The vaccine did not produce YF clinical manifestations in any of the NHPs. After immunization, all animals seroconverted demonstrating the ability of the YF vaccine to induce humoral response in Alouatta species. CONCLUSIONS: The present work has demonstrated the safe and immunogenic profile of the existing YF 17DD vaccine in howler monkeys. This knowledge may support further studies with other susceptible monkey species and provide a possible solution for controlling epizootics and preventing the devastation of endangered species.


Subject(s)
Alouatta/immunology , Immunogenicity, Vaccine , Yellow Fever Vaccine/adverse effects , Animals , Female , Male , Species Specificity , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/immunology , Yellow Fever Vaccine/immunology
3.
Biomed Res Int ; 2017: 9840210, 2017.
Article in English | MEDLINE | ID: mdl-28798938

ABSTRACT

Leishmaniasis remains a serious public health problem in developing countries without effective control, whether by vaccination or chemotherapy. Part of the failure of leishmaniasis control is due to the lack of new less toxic and more effective drugs able to eliminate both the lesions and the parasite. Oxiranes derived from naphthoquinones now being assayed are promising drugs for the treatment of this group of diseases. The predicted pharmacokinetic properties and toxicological profiles of epoxy-α-lapachone and epoxymethoxy-lawsone have now been compared to those of meglumine antimoniate, and histological changes induced by these drugs in noninfected BALB/c mice tissues are described. Effects of these compounds on liver, kidney, lung, heart, and cerebral tissues of healthy mice were examined. The data presented show that both these oxiranes and meglumine antimoniate induce changes in all BALB/c mice tissues, with the lung, heart, and brain being the most affected. Epoxymethoxy-lawsone was the most toxic to lung tissue, while most severe damage was caused in the heart by epoxy-α-lapachone. Meglumine antimoniate caused mild-to-moderate changes in heart and lung tissues.


Subject(s)
Epoxy Compounds/adverse effects , Leishmaniasis/drug therapy , Meglumine/adverse effects , Organometallic Compounds/adverse effects , Animals , Epoxy Compounds/pharmacology , Meglumine/pharmacology , Meglumine Antimoniate , Mice , Mice, Inbred BALB C , Organ Specificity , Organometallic Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL